Data Report Of Dye Listed Companies In The First Half Of 2015

Dyes in the first half of 2015

The company takes full advantage of its brand, patent, technological innovation, environmental protection and cost control to enhance market share and strive to maintain a high level of profitability.

In the 1-5 month, the price of dyestuff was on the rise. In June, the price of dyestuff was reversed. Under the condition of weak demand, the price dropped rapidly, and the upstream intermediates fluctuated. The performance of dye listed companies was adversely affected.

according to

In the first half of 2015, a listed company reported that the data of the operating income of six listed companies were extracted.

Data show that four of the six listed companies declined year by year, and the two companies rose year by year, and the overall revenue situation was less than that of the same period last year.

In the first half of 2015, the ranking of business income was Zhejiang Longsheng, run earth shares, p shares, Jiangsu Asia, Haixiang pharmaceutical and anochi.

Zhejiang Longsheng ranked first, operating income in the first half of the year was about 7 billion 589 million yuan, about the sum of the other five listed companies.

By integrating Longsheng and de star's respective technologies, services,

With the advantages of channel, capacity, cost and technological innovation, the company has become the largest producer of textile chemicals in the world. It has more than 300 thousand tons of dye production capacity and an annual capacity of 100 thousand tons of auxiliaries, ranking the first in the global market.

The company has an annual capacity of 100 thousand tons of intermediate capacity and excellent quality management capabilities, integrated production costs and environmental advantages, as well as long-term business cooperation with DuPont and other well-known international companies, so that the company's intermediates business to maintain sustained and rapid growth.

The shares of intercontinental stock company ranked second, but the biggest decline in the current period, down 16.33% from the same period last year.

According to the report, the international and domestic macroeconomic situation is more complex, and the demand for textile dyeing and printing industry in the downstream of dyestuff industry is weak, and the sales volume of products has declined year by year.

The total annual dye production capacity of the company is over 160 thousand tons, of which the disperse dye capacity is 110 thousand tons, the reactive dye capacity is 40 thousand tons, and other dyes are 10 thousand tons.

The advantage of scale reduces the unit cost of products and promotes the comprehensive utilization of resources of enterprises.

During the reporting period, the company faced the severe situation of overcapacity in the chemical industry, increasing pressure on environmental protection, and continuous adjustment of the industrial structure. The stock market was closely linked to the general keynote of the annual work. The company achieved sales revenue of 2 billion 253 million yuan, down 12.45% from the same period last year.

Asia's operating income is 1 billion 388 million yuan, the report said, affected by the international and domestic macroeconomic situation, dyestuff industry downstream business climate index continued to slump, the company's main products, especially the VAT market, is facing greater competition pressure.

The company promptly adjusts and optimizes the company's sales policy. Under the complicated and changeable situation, the company has achieved good business results.

During the reporting period, the company achieved sales revenue of 1 billion 388 million yuan, down 2.4% compared with the same period last year.

Hai Xiang pharmaceutical business income increased by 128.02% over the same period, so good data reflect the company's good operation situation.

The main reason for the year-on-year increase is the injection of dye plates, which has increased the overall profitability of enterprises.

In the first half of 2015, the external development environment of the medical and chemical industry is still grim. The company has consistently promoted the development of medicine and dyestuff two wheel drive around the established development goals at the beginning of the year.

Through the reorganization of resource integration, fine management, and optimization of product sales structure, the profitability of the pharmaceutical sector has significantly recovered, and new business has achieved breakthroughs in pharmaceuticals and other new businesses.

With the development of Taizhou's forward investment project, the dyestuff plate has been alleviated, and the output price of reactive brilliant blue series has been stable.

Anso's overall performance has steadily improved and has become a rising star in the dyestuff industry.

The reasons for the rise of the data are summarized as follows: during the reporting period, the production management level and production capacity of Dongying and Jiangsu have been gradually increased, and the production costs have been reduced. As the price of raw materials and the market prices of products have risen, the price of some products has been raised.